Riskpilot← Back to searchSign inGet full accessLophora ApS
APSActiveCVR 39871033Herlev Hovedgade 195AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20184 employeeswww.lophora.com
Revenue 2024
DKK -1,9M
-54% vs 2023
EBITDA margin
136.5%
+49% vs 2023
Equity ratio
21.6%
Financial strength
Net profit 2024
DKK -1,9M
+66% vs 2023
| Revenue | DKK -1,9M | -54% |
| EBITDA | DKK -2,6M | +49% |
| Net profit | DKK -1,9M | +66% |
| Total assets | DKK 17,8M | +463% |
| Equity | DKK 3,8M | +125% |
| Employees | 4 | — |
Legal name
Lophora ApS
CVR number
39871033
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. september 2018
Share capital
DKK 63.313
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med bestyrelsesformanden, eller af den samlede bestyrelse.
Company purpose
Virksomhedens formål er at forske og udvikle lægemidler til behandling af psykiatriske sygdomme.
Address
Herlev Hovedgade 195A
Phone
+4551868482
Email
contact@lophora.com
Website
www.lophora.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 201 | -5.402 | -5.530 | -3.610 | -4.168 | -1.923 |
| Staff expenses | -201 | -1.006 | -2.282 | -1.670 | -987 | -701 |
| EBITDA | 0 | -6.408 | -7.812 | -5.280 | -5.155 | -2.624 |
| Depreciation & amort. | -0 | -0 | -0 | -7 | -7 | -7 |
| EBIT | 0 | -6.408 | -7.812 | -5.287 | -5.162 | -2.630 |
| Net financials | 0 | -10 | -757 | -771 | -1.062 | 299 |
| Profit before tax | 0 | -6.418 | -8.569 | -6.057 | -6.223 | -2.332 |
| Tax | -0 | -1.471 | -2.178 | -1.747 | -838 | -476 |
| Net profit | 0 | -4.947 | -6.391 | -4.311 | -5.385 | -1.856 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 470 | 4.682 | 5.913 | 4.165 | 3.162 | 17.798 |
| Equity | 40 | -2.613 | -9.004 | -13.315 | -15.160 | 3.842 |
| Long-term debt | 0 | 7.000 | 13.269 | 17.070 | 18.115 | 13.801 |
| Short-term debt | 430 | 295 | 1.647 | 409 | 208 | 155 |
| Total debt | 430 | 7.295 | 14.917 | 17.479 | 18.322 | 13.956 |
EBITDA margin
-262379000.0%
This company
15.8%
Market median
-1660626682% vs market
20192024
Equity ratio
21.6%
This company
38.2%
Market median
-43% vs market
20192024
Return on equity
-48.3%
This company
18.4%
Market median
-362% vs market
20192024
Net profit margin
-185608600.0%
This company
8.1%
Market median
-2291464298% vs market
20192024
Asset turnover
-0.11×
This company
1.12×
Market median
-110% vs market
20192024
Debt / equity
3.63×
This company
0.62×
Market median
-485% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-09-17 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BT Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
COMMERCE PHARMA HOLDING ApS | Company | 20.0% | 20.0% | 2020 |
| Individual | 20.0% | 20.0% | 2024 | |
| Individual | 15.0% | 15.0% | 2024 | |
| Individual | 15.0% | 15.0% | 2024 | |
| Individual | 5.0% | 5.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lophora ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Tandrup | Chief Executive Officer | 0 companies |
| Ian Rodney Laquian | Chairman | 0 companies |
| Joseph Donald deBethizy | Board of Directors | 0 companies |